Cargando…

Triple-negative expression (ALDH1A1-/CD133-/mutant p53-) cases in lung adenocarcinoma had a good prognosis

Cancer stem cells (CSCs) are major contributors to the malignant transformation of cells because of their capacity for self-renewal. Aldehyde dehydrogenase1A1 (ALDH1A1) and CD133 are promising candidate of CSC markers in non-small cell lung cancer (NSCLC). Furthermore, TP53 is frequently mutated in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamashita, Naoki, So, Tetsuya, Miyata, Takeaki, Yoshimatsu, Takashi, Nakano, Ryuji, Oyama, Tsunehiro, Matsunaga, Wataru, Gotoh, Akinobu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795115/ https://www.ncbi.nlm.nih.gov/pubmed/35087112 http://dx.doi.org/10.1038/s41598-022-05176-0

Ejemplares similares

ALDH1 & CD133 in invasive cervical carcinoma & their association with the outcome of chemoradiation therapy
por: Javed, Shifa, et al.
Publicado: (2021)

Adenovirus as a Vector and Oncolytic Virus
por: Matsunaga, Wataru, et al.
Publicado: (2023)

Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer
por: Kim, Sung Jeep, et al.
Publicado: (2015)

Clinicopathological Significance of Tumor Stem Cell Markers ALDH1 and CD133 in Colorectal Carcinoma
por: Rezaee, Maryam, et al.
Publicado: (2021)

Paraneoplastic limbic encephalitis due to lung squamous cell carcinoma
por: So, Tetsuya, et al.
Publicado: (2021)

Expression and prognostic value of tumor stem cell markers ALDH1 and CD133 in colorectal carcinoma
por: ZHOU, FEI, et al.
Publicado: (2014)

Comments on the "Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer"
por: Ieni, Antonio, et al.
Publicado: (2016)

Expression of ALDH1A1 and CD133 is associated with the prognosis and effect of different chemotherapeutic regimens in gastric cancer
por: Liu, Wan-Ting, et al.
Publicado: (2019)

Subglottic granuloma after aortic replacement: resection via flexible bronchoscopy after an emergency tracheostomy
por: Nose, Naohiro, et al.
Publicado: (2014)

Association between ALDH1+/CD133+ stem-like cells and tumor angiogenesis in invasive ductal breast carcinoma
por: LV, XINQUAN, et al.
Publicado: (2016)

BMI1, ALDH1A1, and CD133 Transcripts Connect Epithelial-Mesenchymal Transition to Cancer Stem Cells in Lung Carcinoma
por: Koren, Ana, et al.
Publicado: (2016)

Pulmonary dirofilariasis in a 59-year-old man
por: So, Tetsuya, et al.
Publicado: (2014)

ALDH1A1 mRNA expression in association with prognosis of triple-negative breast cancer
por: Liu, Yan, et al.
Publicado: (2015)

The diagnosis of primary cardiac lymphoma was facilitated by computed tomographic coronary angiography
por: Nose, Naohiro, et al.
Publicado: (2014)

The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer
por: Alamgeer, Muhammad, et al.
Publicado: (2013)

I haven't had a good rant recently
Publicado: (2009)

Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC)
por: Ma, Fei, et al.
Publicado: (2017)

Comments on the "Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer" and the "Commentary by Antonio Ieni and Giovanni Tuccari"
por: Fargeas, Christine A., et al.
Publicado: (2016)

ALDH1 Cancer Stem Cell Marker as a Prognostic Factor in Triple-Negative Breast Cancer
por: Panigoro, Sonar Soni, et al.
Publicado: (2020)

Ingenuity of minimally invasive thoracoscopic lobectomy for undiagnosed pulmonary tumour
por: Yamanaka, Sumitaka, et al.
Publicado: (2020)

Protective role of ALDH2 against acetaldehyde-derived DNA damage in oesophageal squamous epithelium
por: Amanuma, Yusuke, et al.
Publicado: (2015)

ALDH1 Bio-activates Nifuroxazide to Eradicate ALDH(High) Melanoma-Initiating Cells
por: Sarvi, Sana, et al.
Publicado: (2018)

The expression of ALDH1 in cervical carcinoma
por: Yao, Tingting, et al.
Publicado: (2011)

ALDH1A3 in CSCs
por: Sullivan, Kelly E., et al.
Publicado: (2017)

KK-LC-1 as a therapeutic target to eliminate ALDH(+) stem cells in triple negative breast cancer
por: Bu, Jiawen, et al.
Publicado: (2023)

Evaluation of ALDH1 expression in ipsilateral breast cancer recurrence
por: Shien, Tadahiko, et al.
Publicado: (2017)

Global Deletion of ALDH1A1 and ALDH1A2 Genes Does Not Affect Viability but Blocks Spermatogenesis
por: Topping, Traci, et al.
Publicado: (2022)

Proliferation‐associated long noncoding RNA, TMPO‐AS1, is a potential therapeutic target for triple‐negative breast cancer
por: Mitobe, Yuichi, et al.
Publicado: (2020)

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer
por: Lugli, A, et al.
Publicado: (2010)

ITGA7, CD133, ALDH1 are inter‐correlated, and linked with poor differentiation, lymph node metastasis as well as worse survival in surgical cervical cancer
por: Yuan, Na, et al.
Publicado: (2022)

Effects of inhalable gene transfection as a novel gene therapy for non-small cell lung cancer and malignant pleural mesothelioma
por: Ichikawa, Misa, et al.
Publicado: (2022)

ALDH Activity Selectively Defines an Enhanced Tumor-Initiating Cell Population Relative to CD133 Expression in Human Pancreatic Adenocarcinoma
por: Kim, Michael P., et al.
Publicado: (2011)

Linking ALDH1 and retinoic acid signaling
por: Markham, Nicholas O., et al.
Publicado: (2019)

Detection of ALDH1 activity in rabbit hepatic VX2 tumors and isolation of ALDH1 positive cancer stem cells
por: Gehlot, Prashasnika, et al.
Publicado: (2016)

MiR-133 Targets YES1 and Inhibits the Growth of Triple-Negative Breast Cancer Cells
por: Zhang, Guochen, et al.
Publicado: (2020)

Aldehyde dehydrogenase 1 (ALDH1) immunostaining in axillary lymph node metastases is an independent prognostic factor in ALDH1-positive breast cancer
por: Guan, Xin, et al.
Publicado: (2021)

The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression—ALDH1A1, CD133, CD44—For Survival and Long-Term Follow-Up of Ovarian Cancer Patients
por: Izycka, Natalia, et al.
Publicado: (2023)

Structure of putative tumor suppressor ALDH1L1
por: Tsybovsky, Yaroslav, et al.
Publicado: (2022)

Silencing of NRF2 Reduces the Expression of ALDH1A1 and ALDH3A1 and Sensitizes to 5-FU in Pancreatic Cancer Cells
por: Duong, Hong-Quan, et al.
Publicado: (2017)

ALDH1 and podoplanin expression patterns predict the risk of malignant transformation in oral leukoplakia
por: Habiba, Umma, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_deduci56k366eltu7gfh04vsst